Issue of Equity
May 04 2010 - 10:32AM
UK Regulatory
TIDMRGT
For immediate release
4 May 2010
ReGen Therapeutics Plc
Issue of Equity
ReGen Therapeutics Plc ("ReGen" or the "Company"), (AIM:RGT) is pleased to
announce that it has conditionally placed 11,550,000 new ordinary shares at 2p
per ordinary share to raise GBP231,000 before expenses for general working capital
purposes.
The 11,550,000 new ordinary shares, which will represent 18.75 per cent of the
enlarged issued share capital of the Company (in aggregate amounting to
61,613,215 ordinary shares on completion of the placing), will rank pari passu
in all respects with the existing ordinary shares in the Company.
Application has been made to the London Stock Exchange for the new ordinary
shares to be admitted to trading on AIM and admission is expected to commence on
or around Monday 10 May 2010.
For further information, please contact:
Percy Lomax
ReGen Therapeutics Plc
Tel: 020 7153 4920
Roland Cornish/Felicity Geidt
Beaumont Cornish Limited
Tel: 020 7628 3396
David Scott/Nick Bealer
Alexander David Securities Limited
Tel: 020 7448 9820
ENDS
[HUG#1411764]
Argent Biopharma (LSE:RGT)
Historical Stock Chart
From Sep 2024 to Oct 2024
Argent Biopharma (LSE:RGT)
Historical Stock Chart
From Oct 2023 to Oct 2024